The influence of pH on dissolved organic matter fluorescence in inland waters.

Fluorescence is an easily available analytical technique used to assess the optical characteristics of dissolved organic matter (DOM). Despite widespread use, there has been some confusion about how robust fluorescence spectroscopy is to differences in solution pH. Here we assess fluorescence characteristics of three natural water samples and one commercially available standard (Nordic Reservoir) by modifying the pH across a range from 3.5 to 9.0 at 0.5 pH increments. We used two statistical approaches to assess if fluorescence intensity shifted significantly across this pH range. We identified that humic-like and protein-like fluorescence was largely stable within the pH range of 5.5 to 7.5, which represents 80% of Swedish lakes and streams. Likewise, we found that the three commonly used fluorescence indices were robust across the full pH range tested with the exception of the humification index, which had a narrower range of stability. The commerical humic substance sample was highly unstable with changes to pH in the regions of protein-like fluorescence being particularly sensitive. One of our conclusions is that differences in fluorescence intensity in the pH range of 5.5 to 7.5, typical for most inland waters, are generally minor. We recommend adjusting the pH when samples fall outside this region and to be especially careful in interpreting results from commercial humic substances.

Using quality indicators to compare outcomes of permanent cardiac pacemaker implantation among publicly and privately funded patients.

BACKGROUND: Funding source/insurance status has been associated with disparity in the management and outcomes of cardiovascular disease, with poorer outcomes among disadvantaged groups. AIM: Using proposed quality indicators for permanent pacemaker (PPM) implantation and administrative data, this study aimed to determine whether quality indicator-based outcomes of PPM implantation were comparable for publicly and privately funded patients within Australia's two-tier health system. METHODS: A population-based cohort study of adults implanted with a PPM between 1995 and 2009 in Western Australia. The association of funding outcomes derived from linked administrative data was tested in multivariate logistic regression models. RESULTS: There were 9748 PPMs implanted, 48% being among privately funded patients. The mean age was 75 years for both public and private patients. Private patients had better health status (fewer with cardiac conditions and lower non-cardiac comorbidity scores), were less likely to be an emergency admission (33% vs 60%, P < 0.001) and more likely to have dual- or triple-chamber pacing. Mean length of stay was significantly greater for private patients (4.3 (standard deviation 6.3) vs 5.1 (6.8) days <0.001), related to longer elective admissions. Crude mortality was lower for private patients in-hospital (0.7 vs 1.3%), 30-day post-procedure (1.3 vs 2.1%) and at 1 year (7.3 vs 9.5%). Emergency admission, comorbidity and other demographic and clinical factors, not funding source, were significant predictors of these outcomes. CONCLUSIONS: There was no difference between publicly and privately funded patients in study outcomes, after adjustment for demographic and clinical factors. The exception was longer hospital stay for elective PPM among privately funded patients.

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.

We investigated common genetic variation in the entire ESR1 and EGF genes in relation to endometrial cancer risk, myometrial invasion and endometrial cancer survival. We genotyped a dense set of single-nucleotide polymorphisms (SNPs) in both genes and selected haplotype tagging SNPs (tagSNPs). The tagSNPs were genotyped in 713 Swedish endometrial cancer cases and 1567 population controls and the results incorporated into logistic regression and Cox proportional hazards models. We found five adjacent tagSNPs covering a region of 15 kb at the 5' end of ESR1 that decreased the endometrial cancer risk. The ESR1 variants did not, however, seem to affect myometrial invasion or endometrial cancer survival. For the EGF gene, no association emerged between common genetic variants and endometrial cancer risk or myometrial invasion, but we found a five-tagSNP region that covered 51 kb at the 5' end of the gene where all five tagSNPs seemed to decrease the risk of dying from endometrial cancer. One of the five tagSNPs in this region was in strong linkage disequilibrium (LD) with the untranslated A61G (rs4444903) EGF variant, earlier shown to be associated with risk for other forms of cancer.

Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice.

The efficacy and safety of oral anticoagulation (OA) with vitamin K antagonists depends on maintaining anticoagulation intensity, measured as international normalized ratio (INR), within defined target ranges. We assessed the quality of our current software-assisted warfarin dosing in the year 2006 in 941 unselected consecutive patients on stable OA with atrial fibrillation (AF), venous thromboembolism (VTE) and prosthetic heart valves (PHV) by comparing it to our previous cardiologist-based dosing practice in 1992 when a study was carried out on 241 comparable patients. Over 14 years, the time within target range increased in all three anticoagulated groups, i.e. in AF patients from 46% to 81%, in VTE patients from 62% to 84% and in patients with PHV from 40% to 64%. Only 1% of the treatment time is now spent at INR < 1.5 compared to 7% previously (P < 0.0001) and 0.4% of the treatment time at INR > 4.0 presently compared to 2.8% in the past (P < 0.0001). INR-targets are better achieved with the current software-assisted dosing practice and extreme low and high values are less common than previously. The results provide indirect evidence suggesting that both efficacy and safety has improved with the current practice.

Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality.

We have demonstrated previously that carriers of a genotype called C4B*Q0 (silent allele of the C4B gene) have a substantially increased risk to suffer from myocardial infarction or stroke, and are selected out from the healthy elderly population. Because smoking carries a major risk for cardiovascular disease (CVD), it seemed worthwhile to study if these two factors interact. Study 1 involved 74 patients with angina pectoris (AP), 85 patients with recent acute myocardial infarction (AMI) and 112 survivors of a previous AMI and 382 controls from Iceland. Study 2 involved 233 patients with severe CVD and 274 controls from Hungary. Smoking habits were registered for each subject. The number of C4A and C4B genes was determined by phenotyping or genotyping. Compared to controls, C4B*Q0 carrier frequency was significantly higher at diagnosis in Icelandic smokers with AP (P = 0.005) and AMI (P = 0.0003) and Hungarian smokers with severe coronary artery disease (P = 0.023), while no such difference was observed in non-smoking subjects. Age-associated decrease in C4B*Q0 observed previously in two remote Caucasian populations was found, in the present study, to be associated strongly with smoking, and to already occur in smokers after age 50 years both in Iceland and Hungary. Our findings indicate that the C4B*Q0 genotype can be considered as a major covariate of smoking in precipitating the risk for AMI and associated deaths.

[A prospective study of oral anticoagulation therapy monitored with the P&P-test.].

OBJECTIVE: To analyze the outcome of patients on oral anticoagulation therapy who are monitored with the prothrombin proconvertin time (P&P-test, PP). MATERIAL AND METHODS: The prothrombin-proconvertin time was used to adjust anticoagulant intensity in a prospective study of 326 patients treated with oral anticoagulants for a study period of 121 patient years. The goal intensity INR was 2.0-3.0 for all patients. The main indications were: artificial heart valves 26%, venousthromboembolism 25%, atrial fibrillation 23%, atherosclerotic disease 14% and systemic arterial embolism of uncertain etiology 7%. RESULTS: INR calculated directly from the PP correlated well with INR calculated from the PT. The mean time adjusted anticoagulant intensity was 2.3 and did not differ significantly according to indication. Six major bleedings, including one fatal, occurred in five patients during the study period. The INR was 1.8 in one patient who bled from a duodenal ulcer, but 6.8,7.9,8.6,11.6 (died) and 15.5 at five other events. The INR was <4.5 during 97% of the treatment time of the whole group and 1% of treat notment time were at an INR>6.0. The bleeders had a different pattern with 18% of the treatment time at INR>6.0. The risk of bleeding was one for every 73 days at that intensity or an almost 600 fold risk increase compared to an INR<4.5. One patient anticoagulated for systemic embolism had cerebral infarction with an event related INR of 2.0. Two patients with atrial fibrillation died from acute myocardial infarction but event related INR's were not available. One patient anticoagulated for venous thromboembolism died suddenly but was not autopsied. No embolic events occurred in patients with artificial heart valves in spite of the low intensity anticoagulation. CONCLUSION: Despite a relatively low intensity in all patient groups in this study thromboembolic events were rare. The risk of bleeding increased markedly at INR>6.0. The mortality rate of the ariticoagulated population was comparable to the expected age adjusted Icelandic mortality rate.

Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.

Outcome and anticoagulation intensity was evaluated during 121 patient years of oral anticoagulant therapy monitored with the prothrombin-proconvertin clotting time (PP, also known as P&P). The PP-based international normalized ratio (INR; PP-INR) correlated well with the INR calculated from the prothrombin clotting time (PT; r = 0.92), and results were almost identical over a wide range after linear conversion (1/INR). When the PP-INR was 4.5 or less, the risk of major bleeding was 1 for every 118 treatment years, but it was 1 for every 73 days when the INR was 6 or more. The 1/PP-INR correlated better with factor II coagulant activity (r = 0.85) than did the 1/PT-INR (r = 0.78). The 1/PP-INR also correlated better with the native prothrombin antigen (r = 0.76) than did the 1/PT-INR (r = 0.68). The PP and PT results correlated better with factor II coagulant activity than with native prothrombin antigen. Thus, the PP clotting time results can be accurately converted to INR. The results also suggest that the PP may have advantages over the PT as an indicator of anticoagulation intensity during oral anticoagulation.

Restoring oral health. On the rise and fall of dental caries in Iceland.

During the last decade, a continuous decrease in dental caries has been observed among schoolchildren in Iceland. In this paper, various epidemiological studies have been reviewed and summarized to illustrate caries prevalence, and how it has changed during the last decades. Furthermore, an attempt has been made to describe some of the factors involved and their possible effects on caries disease. During this period, sugar consumption increased, especially in the form of sweets and soft drinks. At the same time, the import of toothpaste increased, and preventive measures such as fissure sealants and fluoride rinsing programs were intensified. Other factors likely to have had an impact were changes in treatment philosophy and increased personnel resources. There does not seem to be any single factor responsible for the onset of the caries decline. It rather looks as if this was a multifactorial effect due to a number of different preventive measures. During recent years, a change in treatment philosophy, the evident increase in fluoride toothpaste consumption, and possible changes in the oral microbial flora, together with the use of fluoride varnishes, sealants, and increased manpower, may explain the decline.

Nutritional status, energy and protein intake in general medical patients in three Nordic hospitals.

The energy and protein intake before and during hospitalization was studied in 56 elderly patients (age 70 +/- 9 yr) admitted to general medical service in three Nordic hospitals. Nutritional status at admission was evaluated using weight index, arm muscle circumference, triceps skinfold, serum albumin, total iron-binding capacity, haemoglobin and serum iron levels. A history of food intake before hospitalization was taken at admission. Food intake during hospital stay was estimated from precise weighing and recording and intake of energy and protein calculated. On admission, 16 patients (28.5 per cent) had three or more of the studied nutritional parameters below reference value. Mean energy intake for men at home and in hospital was 10.0 +/- 2.3 MJ/d and 7.1 +/- 1.3 MJ/d, respectively, and for women 7.8 +/- 1.7 MJ/d and 6.6 +/- 1.4 MJ/d, respectively. Mean protein intake for men at home and in hospital was 72 +/- 19 g/d and 74 +/- 15 g/d, respectively, and for women 60 +/- 15 g/d and 68 +/- 13 g/d, respectively. In patients with a hospital stay exceeding two weeks a correlation between changes in body weight and energy intake was found. Likelihood of developing undernutrition during hospitalization, defined as a daily energy intake below 90 kJ/kg BW per day, was seen in 20 patients (36 per cent). The data obtained indicate that at least 120 kJ/kg should be regarded as necessary to maintain body weight in elderly general medical patients. It reveals the importance of regular nutritional assessment of these patients.